RMIT and EVERAU announce winners of the 2026 student design award for sheepskin shoemaking
RMIT has partnered with Australian premium sheepskin footwear brand EVERAU to announce the winners of its 2026 Student Design Award for Sheepskin Shoemaking.
Statement: Canvas cyber incident
RMIT has been notified of a cyber incident impacting the Canvas learning management system.
Soaked through? Why your rain jacket might not keep you dry
Heading into the colder months, you may have discovered that your rain jacket isn’t as waterproof as you had hoped. An RMIT expert explains the science behind waterproof clothing and how to extend the life of your jacket.
RMIT drives a regenerative future at CEDA Climate and Energy Summit
RMIT regenerative futures expert Chris Speed led a panel at the CEDA Climate and Energy Summit ahead of the launch of the RMIT Regenerative Futures Institute in May. He was joined by industry leaders Renée Wootton Tomlin, Kate Dundas and Philippa Abbott.
Reducing the sting of rising health insurance costs
Private health insurance premiums rose more than four per cent on average in April, leading people to consider asking their health insurer for a better deal. RMIT experts share five tips to help Australians negotiate a better deal.
How hate speech legislation changes can influence artistic expression
New hate‑speech laws introduced in Queensland have raised questions about how legislation designed to limit harm may extend into artistic expression. An RMIT expert explains what the changes could mean for musicians and freedom of expression.
Why are airlines simultaneously raising and slashing fares?
Despite rising fuel costs, major airlines are announcing millions of discounted airfares in attempt to increase bookings. An RMIT expert explains the complexities currently facing the market.
Evidence, not pressure, should guide drug policy decisions
Recent debate around harm‑reduction measures in Victoria has renewed focus on how drug policy decisions are made. This comes at a time with fatal overdoses reportedly at a ten‑year high and a decision by the Victorian government to not proceed with a second supervised injecting facility in Melbourne’s CBD. An RMIT expert explains.
